Bruker Profit Margin

The latest profit margin for BRKR is -0.34% as of March 2026. That compares with 2.31% in the prior-year period — down 114.5% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Bruker's historical trend and sector peers before judging valuation or financial health.

Over the past year, BRKR's profit margin moved from 2.31% to -0.34% — a 114.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bruker's valuation or profitability profile.

Against Healthcare companies, BRKR currently prints -0.34% for profit margin, while the sector average sits near 15.58%. That is roughly 102.2% below the sector mean. Large gaps often invite a closer look at Bruker's growth, margins, and balance sheet.

Profit Margin shows how effectively Bruker converts resources into returns. At -0.34%, BRKR may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 2.31% in the prior-year period — down 114.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BRKR's profit margin (-0.34%), review year-over-year change from 2.31%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.